FibroGen, Inc. logo

FibroGen, Inc.

NASDAQ:FGEN

Overview | Financials
Company Name FibroGen, Inc.
Symbol FGEN
Currency USD
Price 0.39
Market Cap 39,156,390
Dividend Yield 0%
52-week-range 0.33 - 2.93
Industry Biotechnology
Sector Healthcare
CEO Mr. Thane Wettig
Website https://www.fibrogen.com

An error occurred while fetching data.

About FibroGen, Inc.

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the

Related Stocks

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

19.29 USD

Cutera, Inc. logo

Cutera, Inc.

CUTR

0.687 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.17 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

11.54 USD

Avid Bioservices, Inc. logo

Avid Bioservices, Inc.

CDMO

8.83 USD

Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

PAHC

19.46 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

5.04 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

41.12 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

19.1 USD

ImmunoGen, Inc. logo

ImmunoGen, Inc.

IMGN

31.235 USD

Financials

Numbers are in millions USD

Numbers are in millions USD